These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2423798

  • 21. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
    Antani J, Buckle JW, Turner J, Cohen M.
    Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
    [Abstract] [Full Text] [Related]

  • 22. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J.
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [Abstract] [Full Text] [Related]

  • 23. The long-term antihypertensive effects of prazosin and atenolol.
    Itskovitz HD, Krug K, Khoury S, Mollura JL.
    Am J Med; 1989 Jan 23; 86(1B):82-6. PubMed ID: 2913776
    [Abstract] [Full Text] [Related]

  • 24. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension.
    Yajnik BH, Shah JS.
    J Assoc Physicians India; 1985 May 23; 33(5):339-43. PubMed ID: 3900029
    [No Abstract] [Full Text] [Related]

  • 25. Prazosin: a review of clinical experience in hypertension.
    Packard RS.
    Ther Umsch; 1981 May 23; 38 Suppl():28-32. PubMed ID: 6122285
    [No Abstract] [Full Text] [Related]

  • 26. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y, Gagné C.
    J Hum Hypertens; 1993 Apr 23; 7(2):149-52. PubMed ID: 8510087
    [Abstract] [Full Text] [Related]

  • 27. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN, Weidmann P, Riesen W, Claessens J, Streulens Y, Nelemans F.
    Am J Cardiol; 1987 May 29; 59(14):99G-104G. PubMed ID: 2884861
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive therapy in the Federal Republic of Germany: clinical practice experience with indoramin (Wydora).
    Grube E, Giesing M.
    J Cardiovasc Pharmacol; 1986 May 29; 8 Suppl 2():S43-7. PubMed ID: 2423796
    [Abstract] [Full Text] [Related]

  • 29. Forearm and finger hemodynamics, blood pressure control, and lipid changes in patients with diabetic hypertension treated with atenolol and prazosin.
    Kwan CM, Shepherd AM, Johnson J, Taylor WF.
    Clin Pharmacol Ther; 1988 Aug 29; 44(2):202-10. PubMed ID: 3293875
    [Abstract] [Full Text] [Related]

  • 30. Effects of prazosin, atenolol, and thiazide diuretic on plasma lipids in patients with essential hypertension.
    Neusy AJ, Lowenstein J.
    Am J Med; 1986 Feb 14; 80(2A):94-9. PubMed ID: 3511694
    [Abstract] [Full Text] [Related]

  • 31. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M, Cohen M, Marrott PK, Pascucci VL.
    J Cardiovasc Pharmacol; 1986 Feb 14; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [Abstract] [Full Text] [Related]

  • 32. Initial antihypertensive therapy. Comparison of prazosin and hydrochlorothiazide.
    Alderman MH, Davis TK, Carroll L.
    Am J Med; 1986 Feb 14; 80(2A):120-5. PubMed ID: 3511691
    [Abstract] [Full Text] [Related]

  • 33. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G, Korn A.
    Wien Med Wochenschr; 1985 Sep 15; 135(17):425-30. PubMed ID: 4060742
    [Abstract] [Full Text] [Related]

  • 34. [Prazosin in the treatment of hypertension: effect on lipid metabolism].
    Hitzenberger G, Neumann K, Dietz S, Egger H, Hariri K, Kittler E, Niedrist W, Nitsch-Fritz R, Ravanelli O, Sapinsky H.
    Wien Med Wochenschr; 1987 Nov 30; 137(22):525-30. PubMed ID: 3433787
    [Abstract] [Full Text] [Related]

  • 35. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E, Velasco M, Silva H, Camejo G.
    Biomed Biochim Acta; 1987 Nov 30; 46(1):111-8. PubMed ID: 3107546
    [Abstract] [Full Text] [Related]

  • 36. Alpha-adrenoreceptor blockade with indoramin in hypertension.
    Gould BA, Mann S, Davies AB, Altman DG, Raftery EB.
    J Cardiovasc Pharmacol; 1983 Nov 30; 5(3):343-8. PubMed ID: 6191130
    [Abstract] [Full Text] [Related]

  • 37. Indoramin.
    Lancet; 1981 Jun 06; 1(8232):1243-4. PubMed ID: 6112572
    [No Abstract] [Full Text] [Related]

  • 38. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
    Velasco M, Hurt E, Silva H, Urbina-Quintana A, Hernández-Pieretti O, Feldstein E, Camejo G.
    Am J Med; 1986 Feb 14; 80(2A):109-13. PubMed ID: 3080882
    [Abstract] [Full Text] [Related]

  • 39. Prazosin-new hypertensive agent. A double-blind crossover study in the treatment of hypertension.
    Schirger A, Sheps SG.
    JAMA; 1977 Mar 07; 237(10):989-91. PubMed ID: 13230
    [Abstract] [Full Text] [Related]

  • 40. Effects of prazosin and labetalol on blood pressure control and blood lipid levels in patients with mild-to-moderate essential hypertension.
    Farry JP, Fischl SJ, Tighe MJ, Krell MJ.
    Am J Med; 1989 Jan 23; 86(1B):41-4. PubMed ID: 2643864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.